Roche Aktie

315,40 EUR +2,50 EUR +0,80 %

20:25:21

L&S

298,40 CHF +3,10 CHF +1,05 %

17:39:06

SWX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.249,37 Mrd. EUR

KGV24,60Div. Rendite3,80%

WKN855167

ISINCH0012032048

SymbolRHHVF

Roche Aktien News

Sortieren:Datum Meistgelesen

13.04.23GlobeNewswireRoche data highlights strength of ophthalmology portfolio and commitment to advancing eye care at ARVO 2023

11.04.23PR NewswireRoche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care

22.03.23GlobeNewswireRoche announces collaboration with Lilly to enhance early diagnosis of Alzheimer's disease

20.03.23GlobeNewswireNew four year data for Roche’s Evrysdi reinforce long-term efficacy and safety profile in some of the most severely affected people with types 2 and 3 spinal muscular atrophy (SMA)

14.03.23GlobeNewswireRoche Annual General Meeting 2023

10.03.23GlobeNewswireFDA Advisory Committee votes in favour of the clinical benefit of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma

06.03.23PR NewswireRoche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo

28.02.23PR NewswireRoche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics

23.02.23GlobeNewswireRoche launches two new antibodies to identify key clinical mutations in patients with brain cancer

10.02.23GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Transaction in Roche bearer shares

10.02.23GlobeNewswireNew phase III data show Roche’s Vabysmo rapidly improved vision and reduced retinal fluid in people with retinal vein occlusion (RVO)

09.02.23PR NewswireRoche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics

30.01.23PR NewswireJana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease

15.12.22PR NewswireNew Survey Shows Many Americans Are Confused by Testing Options for COVID-19 and Flu

05.12.22PR NewswireRoche Announces Brad Moore as President and CEO of Roche Diagnostics North America

15.11.22PR NewswireJnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases

15.11.22PR NewswireRoche receives FDA approval for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE

14.11.22GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease

10.11.22PR NewswireRoche launches Pilot brand, expands retail channels for COVID-19 At-Home Test

09.11.22GlobeNewswireSTRONG-HF study results demonstrate clear benefits for acute heart failure patients

04.11.22PR NewswireRoche introduces the navify brand for its digital health solutions at HLTH 2022

03.11.22GlobeNewswireRoche to present data at ASH 2022 showcasing strength of haematology portfolio and expanding into new areas to address more patient needs

27.10.22GlobeNewswirePositive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO)

26.10.22GlobeNewswireEarly treatment with Roche's OCREVUS leads to reduced disease progression and healthcare costs; nine-year safety data reinforce favourable benefit-risk profile

24.10.22GlobeNewswireRoche receives FDA clearance for COVID-19 PCR test for use on cobas 6800/8800 Systems

19.10.22GlobeNewswireRoche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022

18.10.22GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022

12.10.22GlobeNewswireRoche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use

12.10.22GlobeNewswirePositive new data for Roche’s Evrysdi in largest trial ever undertaken in patients with previously-treated spinal muscular atrophy (SMA)

11.10.22GlobeNewswireRoche launches PRAME (EPR20330) Antibody to identify PRAME protein expression in patients that may have melanoma

05.10.22GlobeNewswireRoche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022

04.10.22GlobeNewswireRoche receives FDA approval for first companion diagnostic to identify patients with HER2 low metastatic breast cancer eligible for ENHERTU

03.10.22GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Corporate Executive Committee in January 2023

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.